TIGIT expression is upregulated and DNAM-1 expression in CD8+ TILs is decreased in melanoma and AML patients, indicating the role of a TIGIT/DNAM-1 imbalance in tumor progression. This evidence concerns the gene CD8A and acute myeloid leukemia.